Skip to main content
Year archive

aap Implantate AG — 2022 filings

All 30 regulatory filings released by aap Implantate AG (AAQ1) in 2022, sourced directly from the official regulator.

30 Filings
2022 Period
2022 filings (30)
Filing Released Lang
Antibacterial silver coating technology: acceleration of human clinical trial through successfully implemented clinical trial protocol changes
Legal Proceedings Report
2022-11-25 English
Q3/2022: Again significant growth in the US (+45 %) with sales of EUR 1.0 million; total sales and EBITDA impacted by continued volatile market environment
Earnings Release 9M 2022
2022-11-16 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-10-27 English
Q3/2022: Solid third quarter with slight sales growth in persistently volatile market environment; US business back on track with significant +45 % sales increase
Earnings Release Q3 2022
2022-10-25 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-10-21 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-09-30 English
aap launches partnership with strategic investor from the Asian region and resolves on capital increase of around 10 %
Share Issue/Capital Change
2022-09-05 English
Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
Earnings Release H1 2022
2022-08-12 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.01.2022 bis zum 30.06.2022
Interim / Quarterly Report H1 2022
2022-08-12 German
Halbjahresabschluss 2022
Interim / Quarterly Report H1 2022
2022-08-12 German
Report Publication Announcement 2022
Report Publication Announcement
2022-08-11 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
Report Publication Announcement
2022-08-11 German
aap Implantate AG: Q2 weaker than expected and adjustment of guidance for the financial year 2022 due to increased macroeconomic uncertainties in H2
Earnings Release Q2 2022
2022-07-28 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-06-30 English
Q1/2022: Solid start to the year with 6 % sales growth and EBITDA within expectations in a challenging macroeconomic environment
Earnings Release Q1 2022
2022-05-13 English
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 01.06.2022 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2022-05-11 German
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 01.06.2022 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2022-05-11 German
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 01.06.2022 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
Capital/Financing Update
2022-05-11 German
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Audit Report / Information FY 2021
2022-04-12 German
First surgeries performed as part of human clinical study for antibacterial silver coating technology; aap's technology effective against particularly critical antibiotic-resistant hospital germ MRSA
Regulatory Filings
2022-04-06 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-03-31 English
Turnaround in FY/2021: Significant sales growth (+30%) and substantially improved EBIDTA (+84%) - clear trend towards black zero
Earnings Release FY 2021
2022-03-31 English
Jahresfinanzbericht 2021
Annual Report FY 2021
2022-03-31 German
Report Publication Announcement 2022
Report Publication Announcement
2022-03-29 English
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
Report Publication Announcement
2022-03-29 German
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-02-07 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2022-02-03 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-02-02 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-01-31 English
Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022
Earnings Release FY 2021
2022-01-24 English